{
    "LeadSponsorName": [
        "Kyowa Kirin, Inc.",
        "Recepta Biopharma",
        "UCB BIOSCIENCES GmbH",
        "RECORDATI GROUP",
        "Atos Medical AB",
        "Telios Pharma, Inc.",
        "Inovio Pharmaceuticals",
        "Genzyme, a Sanofi Company",
        "Asahi Kasei Pharma America Corporation",
        "PTC Therapeutics",
        "Gilead Sciences",
        "EOM Pharmaceuticals",
        "Apellis Pharmaceuticals, Inc.",
        "Cellectar Biosciences, Inc.",
        "Janssen-Cilag Ltd.",
        "Gamida Cell ltd",
        "Celcuity, Inc.",
        "ISA Pharmaceuticals",
        "Applied Biology, Inc.",
        "Tesaro, Inc.",
        "CancerVax Corporation",
        "Human Genome Sciences Inc., a GSK Company",
        "Anthera Pharmaceuticals",
        "Novartis",
        "Agenus Inc.",
        "medac GmbH",
        "Lavilabor Natural Products Ltd",
        "Jazz Pharmaceuticals",
        "Kronos Bio",
        "Sesen Bio, Inc.",
        "Immix Biopharma, Inc.",
        "Debiopharm International SA",
        "Seagen Inc.",
        "Agios Pharmaceuticals, Inc.",
        "F2G Biotech GmbH",
        "Becton, Dickinson and Company",
        "Hoffmann-La Roche",
        "Loxo Oncology, Inc.",
        "Ultragenyx Pharmaceutical Inc",
        "Threshold Pharmaceuticals",
        "Genentech, Inc.",
        "Viracta Therapeutics, Inc.",
        "CanariaBio Inc.",
        "Immunocore Ltd",
        "Janssen Scientific Affairs, LLC",
        "EMD Serono Research & Development Institute, Inc.",
        "Active Biotech AB",
        "Baxalta now part of Shire",
        "CSL Behring",
        "Immune Biosolutions Inc",
        "Sumitomo Pharma America, Inc.",
        "Cogent Biosciences, Inc.",
        "Shire",
        "Chiltern Pesquisa Clinica Ltda",
        "Cryopraxis Criobiologia Ltda.",
        "Deciphera Pharmaceuticals LLC",
        "PharmaMar",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "ColubrisMX",
        "Astellas Pharma Global Development, Inc.",
        "Bayer",
        "Kartos Therapeutics, Inc.",
        "Principia Biopharma, a Sanofi Company",
        "Morphotek",
        "Humanigen, Inc.",
        "ViiV Healthcare",
        "Recombio SL",
        "Sophia Genetics SAS",
        "Regeneron Pharmaceuticals",
        "Biogen",
        "GlaxoSmithKline",
        "Intercept Pharmaceuticals",
        "Clovis Oncology, Inc.",
        "Eisai Inc.",
        "Acerta Pharma BV",
        "Heidelberg Pharma AG",
        "NantCell, Inc.",
        "Incyte Corporation",
        "Arcus Biosciences, Inc.",
        "Boston Scientific Corporation",
        "Eidos Therapeutics, a BridgeBio company",
        "pharmaand GmbH",
        "Pfizer",
        "Halozyme Therapeutics",
        "Novartis Pharmaceuticals",
        "AstraZeneca",
        "Sandoz",
        "Zodiac Produtos Farmaceuticos S.A.",
        "Exelixis",
        "Crinetics Pharmaceuticals Inc.",
        "Astellas Pharma Inc",
        "Sanofi",
        "NovoCure Ltd.",
        "Ipsen",
        "Corcept Therapeutics",
        "Synta Pharmaceuticals Corp.",
        "Checkpoint Therapeutics, Inc.",
        "Janssen Pharmaceutica N.V., Belgium",
        "Tularik",
        "bluebird bio",
        "Daiichi Sankyo, Inc.",
        "Libbs Farmac\u00eautica LTDA",
        "Mirati Therapeutics Inc.",
        "Xcovery Holding Company, LLC",
        "BioNTech SE",
        "Tobira Therapeutics, Inc.",
        "AbbVie",
        "Spexis AG",
        "OSI Pharmaceuticals",
        "Abbott",
        "Biocinese",
        "EMD Serono",
        "Takeda",
        "Mylan Inc.",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "Spectrum Pharmaceuticals, Inc",
        "Nektar Therapeutics",
        "Janssen Research & Development, LLC",
        "Merrimack Pharmaceuticals",
        "SciClone Pharmaceuticals",
        "Advaxis, Inc.",
        "Azidus Brasil",
        "Millennium Pharmaceuticals, Inc.",
        "Vyriad, Inc.",
        "Janssen-Cilag Farmaceutica Ltda.",
        "mAbxience Research S.L.",
        "Guerbet",
        "RayzeBio, Inc.",
        "R-Pharm",
        "Nereus Pharmaceuticals, Inc.",
        "Abivax S.A.",
        "ArriVent BioPharma, Inc.",
        "Algenis SpA",
        "Alexion Pharmaceuticals, Inc.",
        "UCB Pharma",
        "OncoVerity, Inc.",
        "Isarna Therapeutics GmbH",
        "Celgene",
        "Taiho Oncology, Inc.",
        "Eurofarma Laboratorios S.A.",
        "Akeso",
        "Janssen Sciences Ireland UC",
        "Boehringer Ingelheim",
        "BioMarin Pharmaceutical",
        "Eli Lilly and Company",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Myovant Sciences GmbH",
        "Telik",
        "R-Pharm International, LLC",
        "AbbVie (prior sponsor, Abbott)",
        "Amgen",
        "Aragon Pharmaceuticals, Inc.",
        "Bristol-Myers Squibb",
        "Alaunos Therapeutics",
        "Mallinckrodt",
        "Biozeus Biopharmaceutical S.A.",
        "Merck Sharp & Dohme LLC",
        "Janssen Vaccines & Prevention B.V.",
        "Pierre Fabre Medicament",
        "HUYABIO International, LLC.",
        "OBI Pharma, Inc",
        "Genmab",
        "Scitech Produtos Medicos Ltda",
        "AVEO Pharmaceuticals, Inc.",
        "ApoPharma",
        "Brooklyn ImmunoTherapeutics, LLC",
        "Merck KGaA, Darmstadt, Germany",
        "Basilea Pharmaceutica",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "Tolmar Inc.",
        "Novo Nordisk A/S",
        "Geron Corporation",
        "BeiGene",
        "Helsinn Healthcare SA",
        "Puma Biotechnology, Inc.",
        "Celldex Therapeutics",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Ligand Pharmaceuticals"
    ]
}